# Tarsus Pharmaceuticals Inc. (TARS) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$71M |
| 2024 | -$121M |
| 2023 | -$143M |
| 2022 | -$63M |
| 2021 | -$12M |
| 2020 | -$27M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$6M |
| 2025-09-30 | -$15M |
| 2025-06-30 | -$22M |
| 2025-03-31 | -$26M |
| 2024-09-30 | -$25M |
| 2024-06-30 | -$33M |
| 2024-03-31 | -$38M |
| 2023-09-30 | -$41M |
| 2023-06-30 | -$33M |
| 2023-03-31 | -$25M |
| 2022-09-30 | -$23M |
| 2022-06-30 | -$5M |
| 2022-03-31 | -$20M |
| 2021-09-30 | -$16M |
| 2021-06-30 | $7M |
| 2021-03-31 | $11M |
| 2020-09-30 | -$10M |
| 2020-06-30 | -$3M |
| 2020-03-31 | -$2M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/TARS/operating-income)